Your browser doesn't support javascript.
loading
Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms.
Ye, Xing-Nong; Zhou, Xin-Ping; Wei, Ju-Ying; Xu, Gai-Xiang; Li, Ying; Mao, Li-Ping; Huang, Jian; Ren, Yan-Ling; Mei, Chen; Wang, Jing-Han; Lou, Yin-Jun; Ma, Li-Ya; Yu, Wen-Juan; Ye, Li; Xie, Li-Li; Luo, Yin-Wan; Hu, Chao; Niu, Lin-Mei; Dou, Min-Hua; Jin, Jie; Tong, Hong-Yan.
Affiliation
  • Ye XN; a Institute of Hematology, Department of Hematology , The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China .
  • Zhou XP; b MDS Center, The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China , and.
  • Wei JY; c Department of Hematology , The fourth Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China.
  • Xu GX; a Institute of Hematology, Department of Hematology , The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China .
  • Li Y; b MDS Center, The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China , and.
  • Mao LP; a Institute of Hematology, Department of Hematology , The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China .
  • Huang J; b MDS Center, The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China , and.
  • Ren YL; a Institute of Hematology, Department of Hematology , The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China .
  • Mei C; a Institute of Hematology, Department of Hematology , The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China .
  • Wang JH; a Institute of Hematology, Department of Hematology , The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China .
  • Lou YJ; a Institute of Hematology, Department of Hematology , The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China .
  • Ma LY; c Department of Hematology , The fourth Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China.
  • Yu WJ; a Institute of Hematology, Department of Hematology , The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China .
  • Ye L; b MDS Center, The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China , and.
  • Xie LL; a Institute of Hematology, Department of Hematology , The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China .
  • Luo YW; b MDS Center, The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China , and.
  • Hu C; a Institute of Hematology, Department of Hematology , The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China .
  • Niu LM; a Institute of Hematology, Department of Hematology , The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China .
  • Dou MH; a Institute of Hematology, Department of Hematology , The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China .
  • Jin J; a Institute of Hematology, Department of Hematology , The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China .
  • Tong HY; a Institute of Hematology, Department of Hematology , The first Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou , PR China .
Leuk Lymphoma ; 57(6): 1311-8, 2016.
Article in En | MEDLINE | ID: mdl-26372888

Full text: 1 Database: MEDLINE Main subject: Azacitidine / Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Epigenesis, Genetic Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2016 Type: Article

Full text: 1 Database: MEDLINE Main subject: Azacitidine / Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Epigenesis, Genetic Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2016 Type: Article